| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8531958 | Journal of the American Pharmacists Association | 2017 | 6 Pages | 
Abstract
												Metformin is generally more cost-saving for diabetes prevention than previously reported because of decreasing costs for patients to acquire metformin. The cost savings was increased despite increased management cost associated with addressing metformin-associated vitamin B12 deficiency.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Public Health and Health Policy
												
											Authors
												Nicholas W. Carris, Feng Cheng, William N. Kelly, 
											